Case Study: Paediatric Liver Transplantation with Complex Blood Vessel Abnormalities in a 1 Y.O. Girl

PACE Hospitals

PACE Hospitals’ Liver Transplant team successfully performed Living Donor Liver Transplantation (LDLT) on a 1-year-old female child diagnosed with congenital extrahepatic biliary atresia with biliary cirrhosis following a previous Kasai procedure, with poor portal plate development, poor portal drainage, portal vein hypoplasia, absent suprahepatic inferior vena cava (IVC), annular pancreas, extensive retroperitoneal adhesions, and vascular anomalies. The procedure was performed to replace the diseased liver, restore liver function, and manage the progressive complications associated with advanced biliary atresia.


Chief Complaints

A 1-year-old Baby Girl presented to the Liver Transplant Department at PACE Hospitals, Hitech City, Hyderabad, with jaundice for the past four months, along with intermittent fever.

Past Medical History

The child was a known case of extrahepatic biliary atresia with progressive liver dysfunction. At 45 days of age, she underwent Kasai surgery and duodenojejunostomy. She also had poor portal plate development and poor portal drainage, with associated portal vein hypoplasia, retroperitoneal adhesions, and annular pancreas.


She had a previous history of hospitalisation for viral pneumonia and cholangitis. A liver biopsy demonstrated a biliary obstructive pattern favouring biliary atresia, while imaging showed an atretic gallbladder with an atretic duct.

On Examination

On examination, the child was assessed for her general condition, nutritional status, degree of jaundice, and overall clinical stability. A detailed abdominal examination was performed to evaluate for hepatomegaly, splenomegaly, abdominal distension, and other signs of chronic liver disease. A complete systemic examination was also carried out, along with assessment of hydration status and other relevant clinical parameters, as part of the pre-transplant evaluation.

Diagnosis

Upon admission to PACE Hospitals, Hyderabad, the child underwent a comprehensive clinical evaluation in view of persistent jaundice and intermittent fever following previous Kasai surgery. She was a known case of congenital extrahepatic biliary atresia, a congenital condition in which the bile ducts are absent, underdeveloped, or obstructed, with progressive liver dysfunction.


A detailed medical history, physical examination, and relevant investigations were performed to assess the extent of hepatic and vascular involvement. Previous liver biopsy demonstrated a biliary obstructive pattern favouring biliary atresia, while imaging revealed an atretic gallbladder with an atretic duct. Further evaluation showed biliary cirrhosis, severe cholestasis, portal vein hypoplasia, poor portal drainage, an absent suprahepatic inferior vena cava (IVC), annular pancreas, extensive retroperitoneal adhesions, and associated vascular anomalies.


Based on the clinical findings and investigation results, the child was diagnosed with congenital extrahepatic biliary atresia with biliary cirrhosis, portal vein hypoplasia, absent suprahepatic IVC, annular pancreas, and complex vascular and anatomical abnormalities. Considering the progressive liver dysfunction despite previous Kasai surgery, she was evaluated for Living Donor Liver Transplantation (LDLT). Pre-transplant evaluation included liver function assessment, vascular imaging, laboratory investigations, and other required investigations to determine transplant suitability.


Based on the confirmed diagnosis and progressive liver dysfunction, the child was advised to undergo Congenital extrahepatic Biliary Atresia Treatment along with biliary cirrhosis, portal vein hypoplasia, absent suprahepatic IVC, annular pancreas, and complex vascular and anatomical abnormalities under the supervision of the Liver Transplant Department.

Medical Decision Making (MDM)

After a detailed consultation with Dr. CH. Madhusudhan, (Senior Consultant Surgical Gastroenterologist and Liver Transplant Surgeon), along with Dr. Suresh Kumar, (Liver Transplant Surgeon) a comprehensive evaluation was performed to determine the most appropriate treatment approach.


Considering the child’s history of congenital extrahepatic biliary atresia following previous Kasai surgery, progressive liver dysfunction, biliary cirrhosis, poor portal plate development, poor portal drainage, portal vein hypoplasia, absent suprahepatic inferior vena cava (IVC), annular pancreas, extensive retroperitoneal adhesions, and associated vascular anomalies, further evaluation was undertaken to assess the severity of hepatic and vascular involvement. Previous liver biopsy demonstrated a biliary obstructive pattern favouring biliary atresia, while imaging showed an atretic gallbladder with an atretic duct. Preoperative evaluation also demonstrated severe cholestasis and liver dysfunction.


Based on the clinical assessment and investigation findings, Living Donor Liver Transplantation (LDLT) was considered the most appropriate treatment option to replace the diseased liver and address the progressive hepatic dysfunction associated with congenital biliary atresia.


The child's family were counselled regarding the diagnosis, planned liver transplantation, donor evaluation, expected benefits, potential perioperative risks, postoperative care, immunosuppressive therapy, infection prevention, and the importance of regular long-term follow-up. The necessary pre-transplant investigations and pre-anaesthesia assessment were completed before proceeding with transplantation.

Surgical Procedure

Following the decision, the patient was scheduled for Living Donor Liver Transplantation (LDLT) in Hyderabad at PACE Hospitals, under the supervision of the Liver Transplant Department.

 

The following steps were carried out during the procedure:


  • Preoperative Preparation and Anaesthesia: The child underwent the required preoperative investigations and anaesthesia assessment. The procedure was performed under general anaesthesia with continuous monitoring of vital parameters and organ function.
  • Recipient Liver Removal: The diseased liver was carefully removed after meticulous dissection and control of the major vascular and biliary structures. Extensive retroperitoneal adhesions and complex vascular anatomy required careful surgical handling.
  • Donor Graft Preparation: A left lateral segment graft comprising segments 2 and 3 was prepared from the living donor according to the recipient's requirements. The graft was carefully assessed and prepared for vascular and biliary reconstruction.
  • Graft Implantation and Vascular Reconstruction: The donor graft was placed in the recipient's abdominal cavity. The graft was connected to the recipient's portal vein, hepatic artery, and hepatic vein using appropriate vascular reconstruction techniques and Prolene sutures. Particular attention was given to the absent suprahepatic IVC and associated vascular anomalies.
  • Graft Assessment and Completion of Surgery: Following implantation and vascular reconstruction, the graft was assessed for adequate blood flow and early function. The surgical field was carefully reviewed, and the procedure was completed successfully. The child was subsequently shifted to the ICU for close postoperative monitoring.

Postoperative Care

Following Living Donor Liver Transplantation (LDLT), the child was closely monitored for graft function, liver blood flow, infection, fluid and electrolyte balance, and overall recovery. Supportive treatment was provided to maintain hydration, prevent and manage infections, prevent graft rejection, protect the stomach, and support overall recovery. Liver enzymes improved, and regular Doppler ultrasound showed normal graft perfusion. A transient elevation in white blood cell count with increased lymphocytes was managed conservatively with close clinical monitoring.

Discharge Medications

At discharge, the child was advised to continue medications to prevent rejection of the transplanted liver, prevent and manage infections, protect the stomach, support nutritional recovery, and manage pain, fever, or other symptoms as required. Regular monitoring of liver function, blood counts, renal function, electrolytes, and immunosuppressive drug levels was advised during follow-up.

Advice on Discharge

The parents were advised to give all prescribed medicines regularly, maintain proper hygiene, follow the recommended diet, and attend scheduled follow-ups. They were instructed to seek medical attention for fever, jaundice, abdominal pain, vomiting, or any sudden change in the child’s condition.

Emergency Care

The patient’s parents were advised to contact the emergency ward at PACE Hospitals immediately in case of fever, worsening abdominal pain or swelling, persistent vomiting, difficulty breathing, reduced urine output, worsening jaundice, unusual drowsiness, or any sudden deterioration in the child’s condition.

Review and Follow-up Notes

The patient’s parents were advised to return for a follow-up visit with the Surgical Gastroenterologist after one week, along with the histopathology (HPE) report, to assess postoperative recovery, graft function, wound healing, nutritional status, and overall response following Living Donor Liver Transplantation (LDLT).

Conclusion

This case highlights the successful management of complex congenital biliary atresia with progressive liver dysfunction through Living Donor Liver Transplantation (LDLT). Despite significant vascular and anatomical challenges, the child underwent successful transplantation and received close postoperative monitoring, with normal graft perfusion and clinical improvement.

Medical Disclaimer: This information is for general educational purposes only and does not replace consultation with a qualified liver transplant surgeon or paediatric hepatologist. Treatment decisions and recovery vary depending on the severity of liver disease, graft suitability, vascular anatomy, associated complications, liver function, and other individual clinical factors.

Advancing Pediatric Liver Transplantation

Living Donor Liver Transplantation (LDLT) is an established treatment option for children with advanced liver disease when the native liver can no longer maintain adequate function. Pediatric transplantation requires careful assessment of the child’s condition, donor suitability, graft size, and vascular anatomy before surgery. The procedure involves precise implantation of the donor graft with reconstruction of the hepatic blood supply and bile drainage. Close postoperative monitoring helps assess graft function and identify potential complications at an early stage. Immunosuppressive management, infection prevention, nutritional support, and regular follow-up are essential components of post-transplant care. Timely evaluation and continued care from a liver transplant doctor/specialist can play an important role in improving outcomes and supporting long-term recovery in children with complex liver disease.

Frequently asked questions (FAQs)

  • Why might a child need a liver transplant even after Kasai surgery?

    Kasai surgery is done to improve bile drainage in children with biliary atresia, but liver damage may continue in some children. Over time, they may develop liver scarring, cirrhosis, or reduced liver function. Recurrent cholangitis can further damage the liver. If liver disease progresses despite Kasai surgery, a liver transplant may be recommended.

  • Can a liver transplant be performed in a very young child?

    Yes, liver transplantation can be performed in infants and young children when severe liver disease cannot be adequately managed with other treatments. The child's liver function, nutritional status, general health, and body size are assessed before surgery. The living donor is also thoroughly evaluated for suitability. The transplant team then selects a graft that is appropriate for the child's size.

  • Why is the left lateral segment often used for children?

    The left lateral segment can provide an appropriately sized liver graft for a small child. Before surgery, the transplant team calculates the amount of liver tissue needed for the child. The graft must be large enough to support the child's liver function but not excessively large for the recipient's abdominal space. Donor safety and the amount of liver remaining with the donor are also carefully considered.

  • Does previous Kasai surgery make liver transplantation more difficult?

    Previous Kasai surgery can cause scar tissue and adhesions around the liver and bile duct region. These changes can make the removal of the diseased liver and identification of blood vessels more challenging. The transplant team reviews previous surgical records and imaging before the procedure. This allows the surgeons to plan the operation according to the child's altered anatomy.

  • How are unusual blood vessels managed during liver transplantation?

    Before the transplant, scans are done to assess the child’s blood vessels and identify any anatomical variations. If any abnormality is found, the surgical approach is planned accordingly. During transplantation, the donor liver vessels are connected to the child’s blood vessels to ensure adequate blood flow. Additional vascular reconstruction may be performed when required.

How do doctors know whether the transplanted liver is working properly?

Liver function is checked regularly using blood tests after transplantation. Doppler ultrasound is also used to examine blood flow through the hepatic artery, portal vein, and hepatic veins. The child's clinical condition, liver enzymes, bilirubin levels, and other relevant investigations are followed closely. These checks help doctors identify changes in graft function at an early stage.

Why does a child need anti-rejection treatment after a liver transplant?

After a liver transplant, the child’s immune system may see the new liver as foreign and try to attack it. This can cause rejection of the transplanted liver. Medicines are given to control the immune response and protect the graft. These medicines are usually needed for the long term, with regular check-ups to adjust the treatment when necessary.

What problems should parents look for after the child is discharged?

Parents should watch for fever, increasing jaundice, abdominal pain or swelling, repeated vomiting, reduced urine output, breathing difficulty, or unusual sleepiness. Changes in the child's feeding, activity, or general condition should also be taken seriously. These symptoms may have different causes and should not be ignored after transplantation. The transplant team should be contacted promptly if any concerning change occurs.

Can children return to normal activities after a liver transplant?

Many children are able to return to school, play, and other daily activities after recovering from transplantation. The timing of returning to activities depends on the child's recovery and the advice of the transplant team. Regular medicines, follow-up appointments, and appropriate hygiene remain important. Growth, nutrition, development, and liver function are monitored as the child grows.

Why is long-term follow-up necessary after a liver transplant?

Regular check-ups are needed after a liver transplant, even if the child has no problems. These visits help doctors check liver function, look for rejection or infections, and review the medicines being taken. The child’s growth, nutrition, and development are also monitored. Blood tests or scans may be done when needed to make sure the transplanted liver is working well.


Share on

Request an appointment

Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868

Appointment request - health articles

Recent Articles

World COPD Day, 18 November 2026 - Theme, History and Importance | World COPD Day
By PACE Hospitals • November 17, 2026
World COPD Day 2026, observed on 18 November, raises awareness about COPD, its theme and history, and the importance of early diagnosis and lung health.
World Pancreatic Cancer Day, 19 November 2026 – Theme, History & Importance | Pancreatic Cancer Day
By PACE Hospitals • November 17, 2026
World Pancreatic Cancer Day 2026 raises awareness about its theme, history, risk factors and the importance of early detection and timely treatment worldwide.
Which doctor to consult for a Priapism | Prolonged erection doctor | Priapism specialist
By PACE Hospitals • November 17, 2026
Know which doctor to consult for prolonged painful erection (priapism), and when to see an Emergency Physician, Urologist, or Andrologist at PACE Hospitals.
World Antimicrobial Awareness Week (WAAW) 2026 - Theme and Importance | Antimicrobial Awareness Week
By PACE Hospitals • November 17, 2026
World Antimicrobial Awareness Week 2026 raises awareness about AMR, its theme, importance and global efforts to address antimicrobial resistance worldwide.
National Epilepsy Day, 17 November 2026 - Importance & History | Epilepsy Day
By PACE Hospitals • November 16, 2026
National Epilepsy Day is observed on 17 November 2026 to spread awareness about epilepsy. Explore its importance, historical background, and how it supports early diagnosis.
Cervical Cancer Elimination Day of Action 17 November 2026 – Importance & History
By PACE Hospitals • November 16, 2026
Cervical Cancer Elimination Day of Action 2026, observed on 17 November, its theme and history and the importance of cervical cancer prevention and elimination.